HomeContactSitemapLogin
About InvisionOur PeopleOur InvestmentsNews
  Press Archive 2007Archive 2006Archive 2005Archive 2004Archive 2003EventsPublications

 

ARCHIVE 2003

Thommen Medical closes financing

Waldenburg, November 21, 2003 – Thommen Medical, provider of the SPI® dental implant system, announced today that the company raised CHF 14.1 million in a financing round which was recently closed. A first tranche of CHF 8.1 million was subscribed by the lead-investor Venture Incubator who was joined by new and existing investors BiomedInvest, HBM Bioventures, Invision, Ineo and Acceleration International in June 2003. A second tranche of CHF 6.0 million was recently closed with the participation of new investors Neomed and Genevest as well as two private investors. Thommen Medical has thus been able to attract an experienced syndicate of investors in a difficult financing environment and has significantly broadened its shareholder base.

The company announced as well that they have entered final talks with a Japanese firm. The Japanese partner who has a specialized sales organisation for dental implants and an established customer base, will exclusively distribute the SPI®-implant system in Japan starting in early 2004. A final announcement will be made at a later date.

“The closing of the financing round and entering final talks with our Japanese partner are important milestones for us”, said CEO Andreas Stutz. “They are prerequisites for the future growth of the company. The fact that well-known institutional investors came on board and that a well-known Japanese distributor sees promise in our implant system shows confidence in Thommen Medical and our team”.

Thommen Medical, founded in August 2001, has shown significant growth in its second year and has positioned itself in the market as a recognized provider of a top-class dental implant system and high-level services. Thommen Medical develops and manufactures the SPI®-implant system in Waldenburg and Bettlach (Switzerland) and has their own sales organisations in Switzerland, Germany, Italy and the USA. As of 2004, the SPI®-System will be distributed in Japan.

Contact:
Thommen Medical AG
Andreas Stutz, CEO
Hauptstrasse 87
4437 Waldenburg
Tel. +41 61 965 90 20
andreas.stutz@thommenmedical.com